Ilyang Pharmaceutical Co.,Ltd Stock: price and insider trades · South Korea
일양약품
No insider purchase over the last 90 days. The latest, by 정유석, was filed 30 Jul 2026.
Key facts
Headquarters: Yongin, South Korea · Founded: 1946
Source: Wikidata (CC0).
Who traded when
BuySaleSince the insiders bought
- -22.1%Entry ₩8,930 · Close 30 Oct 2026 ₩6,960
- -22.1%Entry ₩8,930 · Close 30 Oct 2026 ₩6,960
- +3.2%Entry ₩12,640 · Close at T+365 ₩13,050
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 1,699,900 sharesShareKRXDART:20260730000218
- 1,700,000 sharesShareKRXDART:20260730000220Canonical exit: 28 Oct 2026 (T+90)
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 1,050 sharesShareKRXDART:20260528000209Canonical exit: 26 Aug 2026 (T+90)
- 2,030 sharesShareKRXDART:20260528000202Canonical exit: 25 Aug 2026 (T+90)
- 60 sharesShareKRXDART:20260406003986Canonical exit: 30 Jun 2026 (T+90)
- ●Executives0DART
- 88,206 sharesKRXDART:20250430001279Canonical exit: 29 Jul 2025 (T+90)
- 4,100 sharesShareKRXDART:20241018000325Canonical exit: 16 Jan 2025 (T+90)
- 4,000 sharesShareKRXDART:20241017000218Canonical exit: 15 Jan 2025 (T+90)
- ShareKRXDART:20241008000285Canonical exit: 29 Dec 2024 (T+90)
- ShareKRXDART:20240913000552Canonical exit: 5 Dec 2024 (T+90)
- ShareKRXDART:20240814002450Canonical exit: 5 Nov 2024 (T+90)
- ShareKRXDART:20240802000306Canonical exit: 29 Oct 2024 (T+90)
- ShareKRXDART:20240731000517Canonical exit: 22 Oct 2024 (T+90)
25 of 50 declarations
About Ilyang Pharmaceutical Co.,Ltd
정유석, filed as 대표이사 사장 at 일양약품 (Ilyang Pharmaceutical Co.,Ltd), has 28 of the 41 filings in the record, including 8 purchases and no sale. Around this name, 정도언 (10%이상주주) has 6 filings with 4 purchases and 1 sale, 정연찬 (상무이사) and 송화준 (이사) have 2 purchases each, and the company 일양약품 files 2.
The company is a South Korean health care name worth KRW 126.2 billion, with 27.2% of its capital held by insiders; it records 16 purchases and 1 sale, plus 24 filings of another kind. No amount is reported. On May 27 and May 28, 2026, 2 filers bought.
Read moreShow less
The yearly split is very uneven: 19 filings in 2021, then 3 in both 2022 and 2023, 7 in 2024, 2 in 2025 and 7 in 2026. The record covers April 2, 2021 to July 30, 2026. In the last twelve months, 8 filings were lodged (4 purchases, 1 sale). Over the 10 filings whose delay is measured, publication comes a median of 5 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
